Forest Laboratories and Royalty Pharma Announce Acquisition of Furiex Pharmaceuticals

New York, NY - April 28, 2014 – Royalty Pharma announced today that it is partnering with Forest Laboratories (NYSE: FRX) to acquire Furiex Pharmaceuticals (NASDAQ: FURX). Forest is acquiring Furiex for $1.4 billion and Royalty Pharma is acquiring two royalties from Furiex (primarily a royalty on Takeda’s Nesina®), for $415 million in cash.


© 2014 Royalty Pharma, RP Management LLC. All Rights Reserved.